Testosterone replacement therapy (TRT) reduces mortality risk by nearly 50% in men with Klinefelter syndrome (KS), bringing their survival rates closer to those of men from the general population. Men ...
Men with Klinefelter syndrome (KS) showed an increased risk for metabolic conditions such as type 2 diabetes (T2D) and obesity-related disorders, regardless of diagnosis and treatment status.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback